Search

everythinglearnresearchcommunity

for

Search:↓

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

An 8-year-old boy developed a rare condition after a liver transplant, which improved after changing his medication.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Letrozole may help prevent seizures by reducing certain hormone levels.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

A woman with IgG/IgA pemphigus was treated successfully with dapsone and steroids.

Pulsed dye laser treatment was effective for a skin condition resistant to other treatments.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Etretinate has only moderate effects on localized scleroderma and lichen sclerosus.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Abatacept may help some people with alopecia areata regrow hair.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Calcipotriol plus betamethasone with microneedling works better than tacrolimus for treating vitiligo.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

A rash from semaglutide may be due to propylene glycol, not the drug itself.

Solid Lipid Particle technology makes retinol more stable, effective, and gentle on the skin.

Intralesional cidofovir may be a viable alternative treatment for SCC.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Effective treatments for lichen planopilaris are unclear due to inconsistent results and a lack of strong research evidence.

FCER1A and RGS1 may help diagnose and treat systemic lupus erythematosus.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Individualized treatments may help manage Dercum's disease symptoms.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

Social media can help compare the effectiveness and safety of new arthritis medications.